Ozempic Weight-loss drugs to Slow Down Ageing Process, scientists suggest
Drugs for weight loss have the potential to completely transform healthcare by delaying the aging process and extending life expectancy and quality of life. Leading scientists have made this stark statement in response to research that were presented at the European Society of Cardiology Conference in London last week. Studies have already shown that semaglutide , which is marketed under the names Ozempic and Wegovy , lowers the risk of death in patients with cardiovascular disease who are overweight or obese. However, more recent research has shown that Ozempic has effects that go beyond what was once thought to be possible for the medication. Researchers found that those who took the medication died at a decreased rate from all causes, not just cardiovascular ones. "Semaglutide has far-reaching benefits beyond what we initially imagined," Yale School of Medicine Professor Harlan Krumholz stated. It goes beyond just preventing heart attacks. They are advocates for ...